Tribune OnlineTribune OnlineTribune Online
  • Home
  • News
  • Columns
  • Editorial
  • VIDEOS
  • Entertainment
  • Politics
  • Health
  • Opinions
  • SPORTING TRIBUNE
Reading: Breast cancer has cure —Expert
Share
Notification Show More
Font ResizerAa
Tribune OnlineTribune Online
Font ResizerAa
  • Home
  • News
  • Columns
  • Editorial
  • VIDEOS
  • Entertainment
  • Politics
  • Health
  • Opinions
  • SPORTING TRIBUNE
  • About Us
  • Contact us
  • Disclaimer
  • Privacy Policy
  • Advertise
Have an existing account? Sign In
Follow US
© 2026 African Newspapers of Nigeria Plc. All Rights Reserved. | Disclaimer | Privacy Policy | Editorial Policy | Corrections Policy | Terms & Conditions
Home » Breast cancer has cure —Expert
Health

Breast cancer has cure —Expert

David Olagunju
August 1, 2019
Share
From left, Professor Olufunmilayo Olopade; Chief Medical Director, University College Hospital, Ibadan, Professor Abiodun Otegbayo, Dr Atara Ntekim and Professor Sola Olopade, at the event, recently.
Add as a preferred source

Against the backdrop of preventing deaths from breast cancer in Nigeria, a study on a drug that cures breast cancer has commenced at the University College Hospital, Ibadan and three other hospitals in Nigeria.

These are the Obafemi Awolowo University  Teaching Hospital, Ile Ife; Lagos University Teaching Hospital (LUTH), Lagos and the Lagos State University Teaching Hospital.

This trial which will last for two years is being carried out in collaboration with the University of Chicago Medicine, United States of America and Hoffman-LaRoche Pharmaceutical Company.

Presidency yet to received list of ministerial nominees ― Senator Ita…

Unveiling the first clinical trial on cancer treatment in Nigeria, Professor Olufunmilayo Olopade, a cancer treatment expert and the study’s principal investigator said the project was to generate evidence that women in Nigeria can be saved from dying from the most deadly form of breast cancer if treated with the drug.

Prof Olopade stated that the drug has been used to effectively cure women with HER-2 positive breast cancer, the deadliest form of breast cancer that produces a special type of substance called HER-2, in the USA and Europe, for over two decades.

The expert said that HER-2 positive breast cancer was common in Nigerian women and as such the importance of the trial to provide evidence that the drug was good in treating this deadly cancer in Nigeria.

According to her, “Herceptin has not been studied among Nigerians before, although results done among the white populations showed that it is good in treating breast cancer patients that need it. However, it is always good to test drugs in each group of people because it is known that different people react differently to the same drug.

“When we give women this drug, before they remove the tumour from their breast, the tumour melts away. Because it melted away, you have a very high chance that the tumour will never come back.

“Breast cancer is not one disease. You have to know what type it is and then the best drug used to target it. We are in this era of precision medicine; it is no longer guesswork.”

Professor Olopade said that the breast cancer clinical trial was a landmark, as it would be the beginning of a new way of treating cancer patients in Nigeria.

The expert stated that breast cancer incidence was rising in Nigeria and linked this to women now living longer, not breastfeeding, having fewer children, gaining excessive weight, drinking alcohol excessively and inheritance of genes associated with breast cancer.

While assuring that the trial will expand to other geopolitical zones of the country with time, she said all women stood a risk of developing breast cancer and as such should regularly undergo breast cancer screening.

Professor Olapade stated that women with lumps in their breasts or had been diagnosed with breast cancer should not run away from seeking appropriate treatment at the hospital since breast cancer is treatable.

The study’s national principal investigator Dr Atara Ntekim stated that 60 patients newly diagnosed with early stage breast cancer who had not received any prior treatment would be enrolled for the trial.

Dr Ntehim said the study would examine whether the tumour will simply melt away with the cancer drug, test the side effects and quality of life of women undergoing the treatment to better understand how best to support women as they go through cancer treatment. They will also be followed up for over 10 years to see any late side effects and whether cancer will reoccur.

Chief Medical Director, University College Hospital, Professor Abiodun Otegbayo, launching the newly developed protocol for Nigerian women with HER-2 positive breast cancer, stated that Nigeria was long overdue for cancer clinical trials as cancer was one of the greatest killer diseases in Nigeria.

Professor Otegbayo declared that tackling deaths from cancer required having clinical trials to know the best medicines to use and accurate data on cancer cases in the country.

He said the trial would also help build local capacity for clinical trials in the country as well as benefit the numerous patients that are diagnosed annually to have breast cancer.

“This will lead to people coming forward when they know that there is a cure. Most cancers are curable when detected early, but the unfortunate thing is many of our patients come when the disease is at an advanced stage,” Professor Otegbayo said.


WATCH TOP VIDEOS FROM NIGERIAN TRIBUNE TV

  • Back to School, Back to Business A Fresh Start

  • Relationship Hangout: Public vs Private Proposals – Which Truly Wins in Love?

  • “No” Is a Complete Sentence: Why You Should Stop Feeling Guilty

  • Relationship Hangout: Friendship Talk 2025 – How to Be a Good Friend & Big Questions on Friendship

  • Police Overpower Armed Robbers in Ibadan After Fierce Struggle


    Get real-time news updates from Tribune Online! Follow us on WhatsApp for breaking news, exclusive stories and interviews, and much more.
    Join our WhatsApp Channel now


Previous Article fourth revolution, Nigerian leaders, wealth, You and eye, Dr. Ben Ajayi, looking glass, mirrors, window pane, eye, angry man, Big brother, life of crime, law enforcement agencies, anger of the youths, nigerian youth, rate of crime, security officer, Police, policeman, prevention of blindness, hysteria, Diabetes , artificial intelligence, flood, eyes Steroids president, eye injuries, smartphone, Eyebrows, Glaucoma, cavernous sinus Can you define darkness without mentioning light?
Next Article kola nut, kola nut to suppress morning sickness Why kola nut is good for diabetes control

Most Read

  • How to apply for FG's N100,000 family grant
    How to apply for FG's N100,000 family grant
  • TRENDING: JAMB, WAEC join UI, UNILAG, UNILORIN in master’s degree banter
    TRENDING: JAMB, WAEC join UI, UNILAG, UNILORIN in master’s degree banter
  • How to apply for FG’s N100m housing loans
    How to apply for FG’s N100m housing loans
  • Odegbami attacked, macheted at Abeokuta residence
    Odegbami attacked, macheted at Abeokuta residence
  • Dangote Cement records 60 percent reduction in road traffic accidents
    Dangote Cement records 60 percent reduction in road traffic accidents
  • ASUU to Tinubu: Release our withheld salaries now or risk fresh varsity crisis
    ASUU to Tinubu: Release our withheld salaries now or risk fresh varsity crisis
  • AFCON qualifier: Adepoju questions Chelle’s decision to bench Iwobi against Tanzania
    AFCON qualifier: Adepoju questions Chelle’s decision to bench Iwobi against Tanzania
  • 2027: Nigerians have lost confidence in Tinubu — Primate Ayodele
    2027: Nigerians have lost confidence in Tinubu — Primate Ayodele
  • TETFund inaugurates hostel, laboratory, other projects worth over N1.489bn at UNIZIK
    TETFund inaugurates hostel, laboratory, other projects worth over N1.489bn at UNIZIK
  • Why I conceded defeat to Buhari in 2015 – Jonathan
    Why I conceded defeat to Buhari in 2015 – Jonathan

Frontpage Today

Subscribe to e-Paper

E-Vending, e paper, pdf, e-paper, Tribune
QUICK LINKS

About Us
Advertise with Us
Contact Us
Privacy Policy
Disclaimer
Editorial Policy
Corrections Policy
Terms & Conditions
COLUMNS

Aplomb
Ask The Doctor
Autoclinic With The Mechanic
Awo's Thought
Empowered For Life
Festus Adedayo's Flickers
Tuesday Flat Out
Gibbers
Intimacy
Language & Style
Leadership & Management
Lynx Eye
Monday Lines
Mum & Child
Natural Health
Notes from Atlanta with Farooq Kperogi
On The Lord's Day
Your Life Counts

ENTERTAINMENT

Entertainment

RELIGION

Tribune Church
Church News
Muslim Sermon
Eye of Islam
Islamic News

EDITORIAL

Editorial
Opinion
Letters
News Extra

BUSINESS

Capital Market
Money Market

REGIONS

Niger Delta
Arewa
MORE

Sexuality & Health
Special Report
Sports
Tourism
Travelpulse & MICE
Weekend Lagos
Book Review
Education
Event Digest
Crime & Court
Ecoscope
Energy
Maritime
Aviation
Brands & Marketing
Agriculture
Info Tech
Labour
Leadership & Management
Arts & Culture
Arts & Reviews
Politics
Health News
© 2026 African Newspapers of Nigeria Plc. All Rights Reserved. | Disclaimer | Privacy Policy | Editorial Policy | Corrections Policy | Terms & Conditions

Add Tribune Online to your Homescreen!

Add
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?